SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009657
Filing Date
2020-08-06
Accepted
2020-08-06 16:13:25
Documents
83
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20200630x10q.htm   iXBRL 10-Q 2645325
2 EX-31.1 chrs-20200630xex31d1.htm EX-31.1 13877
3 EX-31.2 chrs-20200630xex31d2.htm EX-31.2 14795
4 EX-32.1 chrs-20200630xex32d1.htm EX-32.1 12429
  Complete submission text file 0001558370-20-009657.txt   10173177

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20200630.xsd EX-101.SCH 66454
6 EX-101.CAL chrs-20200630_cal.xml EX-101.CAL 99551
7 EX-101.DEF chrs-20200630_def.xml EX-101.DEF 219187
8 EX-101.LAB chrs-20200630_lab.xml EX-101.LAB 575040
9 EX-101.PRE chrs-20200630_pre.xml EX-101.PRE 436384
10 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20200630x10q_htm.xml XML 2016657
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 201081773
SIC: 2836 Biological Products, (No Diagnostic Substances)